These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31439510)

  • 1. Rare Saposin A deficiency: Novel variant and psychosine analysis.
    Calderwood L; Wenger DA; Matern D; Dahmoush H; Watiker V; Lee C
    Mol Genet Metab; 2020 Feb; 129(2):161-164. PubMed ID: 31439510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic ablation of Saposin-D in Krabbe disease eliminates psychosine accumulation but does not significantly improve demyelination.
    Watanabe T; Tsuboi K; Matsuda N; Ishizuka Y; Go S; Watanabe E; Ono A; Okamoto Y; Matsuda J
    J Neurochem; 2023 Aug; 166(4):720-746. PubMed ID: 37337846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.
    Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K
    Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a newborn screening tool based on bivariate normal limits: using psychosine and galactocerebrosidase determination on dried blood spots to predict Krabbe disease.
    Langan TJ; Orsini JJ; Jalal K; Barczykowski AL; Escolar ML; Poe MD; Biski CK; Carter RL
    Genet Med; 2019 Jul; 21(7):1644-1651. PubMed ID: 30546085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease.
    Iacono D; Koga S; Peng H; Manavalan A; Daiker J; Castanedes-Casey M; Martin NB; Herdt AR; Gelb MH; Dickson DW; Lee CW
    Neurobiol Dis; 2022 Nov; 174():105862. PubMed ID: 36113749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosine, a marker of Krabbe phenotype and treatment effect.
    Escolar ML; Kiely BT; Shawgo E; Hong X; Gelb MH; Orsini JJ; Matern D; Poe MD
    Mol Genet Metab; 2017 Jul; 121(3):271-278. PubMed ID: 28579020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease.
    Chuang WL; Pacheco J; Zhang XK; Martin MM; Biski CK; Keutzer JM; Wenger DA; Caggana M; Orsini JJ
    Clin Chim Acta; 2013 Apr; 419():73-6. PubMed ID: 23419961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease.
    Harzer K; Knoblich R; Rolfs A; Bauer P; Eggers J
    Clin Chim Acta; 2002 Mar; 317(1-2):77-84. PubMed ID: 11814461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease.
    Guenzel AJ; Turgeon CT; Nickander KK; White AL; Peck DS; Pino GB; Studinski AL; Prasad VK; Kurtzberg J; Escolar ML; Lasio MLD; Pellegrino JE; Sakonju A; Hickey RE; Shallow NM; Ream MA; Orsini JJ; Gelb MH; Raymond K; Gavrilov DK; Oglesbee D; Rinaldo P; Tortorelli S; Matern D
    Genet Med; 2020 Jun; 22(6):1108-1118. PubMed ID: 32089546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form.
    Hossain MA; Otomo T; Saito S; Ohno K; Sakuraba H; Hamada Y; Ozono K; Sakai N
    Gene; 2014 Jan; 534(2):144-54. PubMed ID: 24252386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
    Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
    Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans.
    Spiegel R; Bach G; Sury V; Mengistu G; Meidan B; Shalev S; Shneor Y; Mandel H; Zeigler M
    Mol Genet Metab; 2005 Feb; 84(2):160-6. PubMed ID: 15773042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel homozygous GALC variant has been associated with Krabbe disease in a consanguineous family.
    Tuncer FN; Iseri SAU; Yapici Z; Demir M; Karaca M; Calik M
    Neurol Sci; 2018 Dec; 39(12):2123-2128. PubMed ID: 30209698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GALC mutations in Chinese patients with late-onset Krabbe disease: a case report.
    Zhuang S; Kong L; Li C; Chen L; Zhang T
    BMC Neurol; 2019 Jun; 19(1):122. PubMed ID: 31185936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target.
    Li Y; Xu Y; Benitez BA; Nagree MS; Dearborn JT; Jiang X; Guzman MA; Woloszynek JC; Giaramita A; Yip BK; Elsbernd J; Babcock MC; Lo M; Fowler SC; Wozniak DF; Vogler CA; Medin JA; Crawford BE; Sands MS
    Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20097-20103. PubMed ID: 31527255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
    Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
    J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron-specific ablation of the Krabbe disease gene galactosylceramidase in mice results in neurodegeneration.
    Kreher C; Favret J; Weinstock NI; Maulik M; Hong X; Gelb MH; Wrabetz L; Feltri ML; Shin D
    PLoS Biol; 2022 Jul; 20(7):e3001661. PubMed ID: 35789331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the Pathogenesis and Treatment of Krabbe Disease.
    Bongarzone ER; Escolar ML; Gray SJ; Kafri T; Vite CH; Sands MS
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():689-96. PubMed ID: 27491217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular report of novel GALC mutations in Moroccan patient with Krabbe disease: case report.
    Zerkaoui M; Ratbi I; Castellotti B; Gellera C; Lyahyai J; Kriouile Y; Sefiani A
    BMC Pediatr; 2015 Nov; 15():182. PubMed ID: 26567009
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.